FDA NDC Directory · JSON-LD · Markdown

Inveltys

NDC 71571-121 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameloteprednol etabonate
Labeler / ManufacturerALCON LABORATORIES, INC.
Marketing categoryNew Drug Application (innovator) · App NDA210565
Dosage form / routeSUSPENSION · TOPICAL
Active ingredientsLOTEPREDNOL ETABONATE (10 mg/mL)
Marketing started20180822
Package count2

External sources

Source: openFDA. Public-domain (CC0).